Last reviewed · How we verify
NCT03726606
A Comparison of the Visual Performance of Trifocal Versus Extended Depth of Focus Intraocular Lenses
NA trial testing Intraocular lens in Cataract in 36 participants. Status unknown.
6 May 2019
Quick facts
| Lead sponsor | Hashmanis Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 5 November 2018 |
| Primary completion | 6 May 2019 |
| Estimated completion | 6 May 2019 |
Drugs / interventions tested
- Intraocular lens
Conditions studied
- Cataract — all drugs for Cataract →
- Lenses — all drugs for Lenses →
- Visual Impairment — all drugs for Visual Impairment →
Sponsor
Hashmanis Hospital
Who can join
Adults 30 to 70, any sex, with Cataract or Lenses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We are conducting a trial evaluating the performance of trifocal versus extended depth of focus intraocular lenses. These lenses will be implanted in otherwise healthy individuals with visual problems due to bilateral cataracts. Patients must be seeking an improvement in their visual performance with a special focus on presbyopia correction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Trifocal versus extended depth of focus (EDOF) intraocular lenses after cataract extraction.
Tavassoli S, Ziaei H, Yadegarfar ME, Gokul A, et al · · 2024 · cited 21× · PMID 38984608 · DOI 10.1002/14651858.cd014891.pub2
Verify or expand the search:
- PubMed search for NCT03726606
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intraocular lens
Trials testing the same drug.
- NCT05735990 — Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With C · completed
- NCT05541796 — Clinical Outcomes Following Implantation of Tecnis Synergy and Symfony Intraocular Lens · NA · completed
- NCT04907500 — Prospective Evaluation of an Hydrophilic Acrylic Intraocular Lens · NA · completed
- NCT06528678 — Patients Outcomes of a Monofocal Intraocular Lens Designed for Monovision · completed
- NCT04175951 — Tecnis Eyhance Versus Rayner RayOne Study · NA · unknown
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03726606 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hashmanis Hospital
- Last refreshed: 31 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726606.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing